Tuesday, 19 Mar 2019

You are here

Autoimmunity in the Setting of Primary Immunodeficiency

There are many avenues for interdisciplinary collaboration within rheumatology, as our specialty encompasses every organ system and diseases with protean manifestations. The intersection of rheumatology and immunology is well known and has become increasingly important, given the association of autoimmune conditions with many of the primary immunodeficiency syndromes. This intersection was highlighted today at ACR by two excellent abstracts.

The first was presented during the plenary session and was the result of a multi-center collaboration – Screening of patients with adult-onset idiopathic polyarteritis nodosa for deficiency of adenosine deaminiase 2 (DADA2) (abstract #2790). DADA2 is a rare genetic disorder associated with inflammation in various tissues, including vasculitis and risk of stroke.  In particular it is known to be associated with polyarteritis nodosa (PAN). The investigators of this study looked at the prevalence of DADA2 in patients with presumed idiopathic PAN. 117 patients with idiopathic PAN (all negative for hepatitis B) were screened for mutations in ADA2 and 6.8% had rare missence variants in ADA2. While there were no clinical differences between PAN patients with or without these mutations, this may have implications in screening family members as well as for treatment, as TNF inhibitors are often used to treat DAD2, but are not often used for PAN.

The second abstract (#2838), presented by Kevin Byram, was a study examining what are the most common primary immunodeficiency (PID) syndromes associated with vasculitis. They did this by querying the USIDNET, a national consortium of PID patients, for vasculitis cases. 76 patients with vasculitis (out of 4,888 PID cases) were identified. The most common PID associations were common variable immunodeficiency (38%) and Wiskott-Aldrich Syndrome (26%). Interestingly, CNS vasculitis was the most common specific vasculitis syndrome identified (14%), and vasculitis cases were reported to be present before or at the time of PID diagnosis ~50% of the time. While vasculitis is an uncommon complication of PID, it is important for rheumatologists to be aware of this entity.

 

 

 

Add new comment

More Like This

Cyclosporin and IVIG Effective in Kawasaki's Disease

A Lancet study has shown that adding cyclosporin to intravenous immunoglobulin (IVIG) Kawasaki disease patients, who were predicted to be resistant to IVIG, was both safe and effective in averting severe coronary artery outcomes.

Brazilian Guidelines for Systemic Autoimmune Myopathies

The Myopathy Committee of the Brazilian Society of Rheumatology (BSR) has put forward recommendations for the management of patients with systemic autoimmune myopathies (SAM).

The challenge has been that there is a paucity of effective controlled clinical trials, and hence, glucocorticoids (GC) have played a first-line and prominent role in the treatment of SAM.

EULAR Consensus Guidelines for Juvenile Localized Scleroderma

A EULAR international committee of 15 experts in pediatric rheumatology have established consensus-based recommendations for the management of juvenile localised scleroderma (JLS).

JLS is an uncommon disorder that is commonly seen by pediatric and adult rheumatologists. Evidence-based guidelines are sparse and management is mostly based on physicians’ experience.

2018 Swedish Guidelines for Giant Cell Arteritis Treatment

The Swedish Society of Rheumatology has developed evidence-based guidelines for the management of giant cell arteritis (GCA) with a focus on the appropriate use of corticosteroids and tocilizumab. 

Congenital Heart Block: Dangers Ahead

Children of autoantibody-positive mothers who were born with congenital heart block were at high risk for developing later cardiovascular and autoimmune disorders, as were their siblings, Swedish researchers reported.